Last updated: November 11, 2024
Sponsor: Linkoeping University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Circulation Disorders
Soft Tissue Infections
Sepsis And Septicemia
Treatment
Exposure is septic shock (defined according to Sepsis-III) and standard treatment according to departmental protocols.
Clinical Study ID
NCT04695119
SICU-II
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patients admitted to ICU and fulfilling the Sepsis-III criteria for septicshock
Exclusion
Exclusion Criteria:
No informed consent
Acute coronary syndromes
Study Design
Total Participants: 330
Treatment Group(s): 1
Primary Treatment: Exposure is septic shock (defined according to Sepsis-III) and standard treatment according to departmental protocols.
Phase:
Study Start date:
September 17, 2018
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
CHU Dijon-Bourgogne
Dijon, 21000
FranceActive - Recruiting
CHU Georges Pompidou
Paris, 75015
FranceActive - Recruiting
Ryhov Sjukhus Jönköping
Jönköping, 55305
SwedenSite Not Available
Dept of Anaesthesia and Intensive Care
Linköping, 58185
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.